Internal Medicine, Hematology & Oncology · Oxford, MS
NPI
1770870289
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
504 Azalea Dr Ste A
Oxford, MS, 38655
Phone (662) 636-4444
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,857 services
Medicare patients, 2024
484
Average age 74
Drug cost, 2024
$5.8M
2,408 prescriptions
Company payments, 2025
$3,262
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan A Yates was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 689 times for 296 patients. In total Ryan A Yates billed 1,857 services in 12 codes, and Medicare paid $100K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 689 | 296 | $11.26 | $7,758 |
| 99214 Office E&M - Established | Office | 506 | 270 | $66.23 | $34K |
| 99215 Office E&M - Established | Office | 288 | 116 | $102.07 | $29K |
| 99213 Office E&M - Established | Office | 135 | 117 | $38.79 | $5,236 |
| 99233 Hospital E&M - Subsequent | Facility | 111 | 50 | $86.55 | $9,607 |
| 99205 Office E&M - New | Office | 64 | 64 | $124.92 | $7,995 |
| 99223 Hospital E&M - Initial | Facility | 30 | 30 | $126.08 | $3,782 |
| 99204 Office E&M - New | Office | 22 | 22 | $98.10 | $2,158 |
By year: 2022 $106K for 1,361 services; 2023 $84K for 1,070 services; 2024 $100K for 1,857 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ryan A Yates prescribed most often to Medicare patients was Letrozole, with 232 prescriptions and refills. In total Ryan A Yates wrote 2,408 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 232 | 385 | 50 | $2,771 |
| Potassium Chloride Generic | 129 | 142 | 50 | $1,934 |
| Prednisone Generic | 114 | 120 | 22 | $326 |
| Gabapentin Generic | 103 | 137 | 25 | $809 |
| Acyclovir Generic | 75 | 85 | 11 | $423 |
| Ondansetron Odt Ondansetron | 73 | 73 | 47 | $815 |
| Xarelto Rivaroxaban | 72 | 98 | 16 | $53K |
| Tamoxifen Citrate Generic | 70 | 120 | 17 | $1,057 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 55 | 55 | 19 | $957 |
| Dexamethasone Generic | 51 | 51 | 27 | $639 |
| Mirtazapine Generic | 50 | 54 | 14 | $652 |
| Duloxetine Hcl Generic | 49 | 63 | 15 | $525 |
| Verzenio Abemaciclib | 49 | 49 | Under 11 | $724K |
| Eliquis Apixaban | 46 | 50 | 11 | $29K |
| Lenalidomide Generic | 45 | 45 | Under 11 | $623K |
Brand drugs: 466 claims; generic drugs: 1,942 claims; opioid claims: 143.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan A Yates $3,262 ($3,262 in general payments such as food, travel and fees) from 37 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $308.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $308 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $287 |
| Merck Sharp & Dohme LLC MRK | 11 | $253 |
| Janssen Biotech, Inc. JNJ | 11 | $204 |
| Gilead Sciences, Inc. GILD | 8 | $203 |
| Pfizer Inc. PFE | 13 | $189 |
| Celgene Corporation BMY | 8 | $167 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $137 |
| Astellas Pharma US Inc 4503.T | 5 | $119 |
| GlaxoSmithKline, LLC. GSK | 7 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.